All Infection Prevention & Control articles – Page 23
-
NewsResearchers uncover how virus causes cancer, point to potential treatment
Kaposi sarcoma-associated herpesvirus activates a specific pathway to drive viral persistent infection and cell growth, paving the way for tumors to form.
-
NewsResearchers propose ultrasonic power therapy for helicobacter pylori infection
Scientists have developed a nanoparticle-based sonodynamic therapy to reduce H. pylori infection in mice without disrupting gut microbiota.
-
NewsNew antibodies target “dark side” of influenza virus protein
Researchers have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored “dark side” of the neuraminidase (NA) protein head.
-
NewsProtective human monoclonal antibody targets a conserved site of spike glycoprotein of SARS-CoV-2 Omicron variants
Scientists report that mAb-39 greatly improved the neutralizing activity of anti-RBD antibody, the same type of EUA therapeutic monoclonal antibodies, against the highly neutralization-resistant Omicron variants.
-
NewsEvidence needed for preventative measures to stop surgical infections
A new research review will look at improving preventive measures to stop surgical infections. It will also ask why we are doing what we are doing, especially when some interventions lack quality evidence to back them.
-
NewsThe future is personalised care for influenza and flu-like illness
A new research review will focus on a future of more personalised care for diseases such as influenza, so that patients and doctors will be able to more accurately determine when the infectious part of the illness has passed.
-
NewsNew approach may prevent deadly intestinal disease in preemies
Scientists have found that an investigational protein replacement protected neonatal mice from necrotizing enterocolitis (NEC), a deadly intestinal disease that often strikes extremely premature infants.
-
NewsDrug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy
Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens.
-
NewsStudy reveals potential flaw in operating room ventilation that increases risk of Covid infection
Simple modifications to ventilation systems improve airflow, making operations safer for both patients and surgical teams.
-
NewsArtificial intelligence has huge potential in infection control, as long as the right questions are asked and safeguards are in place
Artificial intelligence can help prevent infectious disease outbreaks including ensuring staff wear personal protective equipment correctly and managing day-to-day hospital activities such as medication prescription and cleaning.
-
NewsAI could improve speed and accuracy of response to infectious disease outbreaks in hospitals
A research review will highlight the potential artificial intelligence (AI) has to improve speed and accuracy of investigations into infectious disease outbreaks in hospitals, and potentially provide real time information to stop or prevent them.
-
NewsLow-temperature plasma used to remove E. coli from hydroponically grown crops
A group led by researchers at Nagoya University and Meijo University in Japan has developed a disinfection technology that uses low-temperature plasma generated by electricity to cultivate environmentally friendly hydroponically grown crops. This innovative technology sterilizes the crops, promoting plant growth without the use of chemical fertilizers. Their findings appear ...
-
NewsFusion protein reveals a conservative antigenic domain across herpesviruses
A new study proposes that the gB DII domain within the herpesvirus family constitutes a broadly conserved neutralizing epitope structural domain.
-
NewsComplement system response to AAV vector gene therapy
Recent clinical trials utilizing high doses of adeno-associated virus (AAV) vectors have highlighted a new challenge to AAV gene transfer – activation of the complement system.
-
NewsPhage therapy eradicates pan-resistant priority pathogen in vivo, study shows
A new study describes the use of phage therapy to eradicate multi-drug resistant Pseudomonas aeruginosa infections in a living organism (in vivo) with important new implications to antibiotic resistance.
-
NewsLong-acting HIV treatment demonstrates efficacy in people with challenges taking daily medicine as prescribed
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen, according to interim data from a randomized trial. Source: NIAID Colorized transmission electron micrograph ...
-
NewsScientists win $434k grant to induce microbes to desert their protective biofilm
Researchers are pursuing biofilm dispersal agents such as specific enzymes in hopes the enzymes can induce microbes to leave the safety of the protective biofilm and become more susceptible to antibiotics.
-
NewsUptake of HIV prevention medication doubles with mix of digital health interventions
A combination of interventions of one-on-one telehealth coaching, peer support forums, and automated text messages more than doubled the use of the HIV prevention strategy, called PrEP, among younger, at-risk Americans.
-
NewsPlasma device is giant step forward to help treat chronic wounds that affect millions
A team of international scientists has developed a more effective treatment for chronic wounds that does not involve antibiotics or silver-based dressings, but an ionized gas called plasma. Source: University of South Australia The plasma activates oxygen and nitrogen molecules to treat wounds effectively. The treatment involves ...
-
NewsResearchers are using RNA in a new approach to fight HIV
Scientists have developed a novel nanomedicine loaded with genetic material called small interfering RNAs (siRNA) to fight human immunodeficiency virus (HIV) using gene therapy.